Skip to main content
INSMED Inc logo

INSMED Inc — Investor Relations & Filings

Ticker · INSM ISIN · US4576693075 LEI · 529900Q55QAG41CCAC11 US Manufacturing
Filings indexed 1,323 across all filing types
Latest filing 2021-04-01 Remuneration Information
Country US United States of America
Listing US INSM

About INSMED Inc

https://insmed.com/

Insmed Incorporated is a global biopharmaceutical company dedicated to developing and commercializing therapies for patients with serious and rare diseases. The company's primary focus is on addressing areas of high unmet medical need. Its marketed product, Arikayce (liposomal amikacin for inhalation), is a treatment for Mycobacterium avium complex (MAC) lung disease. Insmed leverages proprietary technologies, such as its advanced liposomal pulmonary delivery system, to create novel treatments. The company maintains a diverse pipeline of investigational medicines and is actively advancing potential new therapies through various stages of clinical trials.

Recent filings

Filing Released Lang Actions
FORM DEFA14A
Remuneration Information Classification · 95% confidence The document is identified as a 'FORM DEFA14A' which is a definitive additional proxy solicitation material filed pursuant to Schedule 14A under the Securities Exchange Act of 1934. The text explicitly states it is a 'Definitive Additional Materials' filing related to a proxy statement. Proxy statements and related solicitation materials fall under the category of 'Remuneration Information' filings when they detail executive compensation or under 'Proxy Solicitation & Information Statement' filings when they provide information and request votes for meetings. Since this is a Schedule 14A filing, it is best classified as 'Remuneration Information' (DEF 14A) which covers proxy statements including executive compensation disclosures. The document length is short (2047 characters) and it is not an announcement of a report but the filing itself. Therefore, the correct classification is DEF 14A with high confidence.
2021-04-01 English
DEF14A
Proxy Solicitation & Information Statement
2021-04-01 English
FORM 4
Director's Dealing
2021-03-18 English
FORM 4
Director's Dealing
2021-03-12 English
FORM 4
Director's Dealing
2021-03-12 English
FORM 4
Director's Dealing
2021-03-11 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.